Artivion | CRY - Cost Of Sales

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $34.77M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 33.15M 208K Feb/2025
Artivion USD 34.77M 75K Sep/2024
AtriCure USD 35.16M 2.23M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Integra LifeSciences USD 195.07M 11.2M Sep/2025
J&J USD 7.97B 689M Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 253.61M 192.05M Dec/2024
Pfizer USD 6.29B 2.12B Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 33.03M 24.58M Sep/2024
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 461.38M 111.57M Sep/2025
Terumo JPY 143.44B 15.47B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025